US2016287541A1PendingUtilityA1
Modified Release Tranexamic Acid Formulation
Est. expiryNov 30, 2030(~4.4 yrs left)· nominal 20-yr term from priority
A61K 9/2846A61K 9/2027A61P 7/04A61K 9/2009A61K 9/2054A61K 31/195A61K 9/2077A61K 9/2013
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A modified release dosage form for the oral administration of tranexamic acid.
Claims
exact text as granted — not AI-modified1 - 24 . (canceled)
25 . A modified release dosage form consisting essentially of:
(A) a compressed matrix core which comprises:
(i) tranexamic acid;
(ii) a release controlling material; and
(iii) a tableting excipient selected from the group consisting of binders, fillers, disintegrants, glidants, lubricants or mixtures thereof;
(B) a functional coating applied to and surrounding the compressed matrix core which comprises:
(i) a coating agent which is insoluble in water but soluble in aqueous media with a pH below 4; and
(ii) a processing aid selected from the group consisting of a binder, filler, pigment, lubricant, plasticizer and mixtures thereof; and
(C) optionally an aesthetic coating.
26 . The modified release dosage form as defined in claim 25 wherein the dosage form is a tablet or mini tablet.
27 . The modified release dosage form as defined in claim 25 wherein the coating agent which is insoluble in water but soluble in aqueous media with a pH below 4 is an aminoalkyl methacrylate copolymer.
28 . The modified release dosage form as defined in claim 25 wherein the compressed matrix core has a hardness of 13-20 kp.
29 . A modified release tablet consisting essentially of:
(A) a compressed matrix core which comprises:
(i) tranexamic acid;
(ii) a release controlling material; and
(iii) a tableting excipient selected from the group consisting of binders, fillers, disintegrants, glidants, lubricants or mixtures thereof;
(B) a functional coating applied to and surrounding the compressed matrix core which comprises:
(i) an aminoalkyl methacrylate copolymer that is insoluble in water but soluble in aqueous media with a pH below 4; and
(ii) a processing aid selected from the group consisting of a binder, filler, pigment, lubricant, plasticizer and mixtures thereof; and
(C) optionally an aesthetic coating, wherein the compressed matrix core has a hardness of 13-20 kp.Join the waitlist — get patent alerts
Track US2016287541A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.